Search

Progyny Inc

Ouvert

SecteurSoins de santé

27.72 1.35

Résumé

Variation du prix de l'action

24h

Actuel

Min

27.34

Max

27.91

Chiffres clés

By Trading Economics

Revenu

28M

52M

Ventes

22M

351M

P/E

Moyenne du Secteur

28.196

56.597

BPA

0.34

Marge bénéficiaire

14.917

Employés

835

EBITDA

5.9M

44M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+24.98% upside

Dividendes

By Acuity

Prochains Résultats

5 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-448M

2B

Ouverture précédente

26.37

Clôture précédente

27.72

Sentiment de l'Actualité

By Acuity

13%

87%

9 / 339 Classement par Healthcare

Progyny Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 sept. 2026, 20:08 UTC

Progyny Inc shares are higher during Friday's session, despite no specific news. The broader market has closed lower, reflecting a cumulative gain since Thursday.

10 sept. 2026, 20:07 UTC

Progyny Inc shares are lower today amid broader market declines and rising Treasury yields. No specific company news has been identified to explain the move.

9 sept. 2026, 20:07 UTC

Progyny Inc shares are lower in Wednesday trading, reflecting broader market trends. Earlier, they pulled back from a session low before recovering somewhat.

8 sept. 2026, 20:02 UTC

News

Citizens raised its price target on Progyny to $33, contributing to positive sentiment. The company reported Q2 revenues of $350.5 million.

3 sept. 2026, 20:07 UTC

News

Progyny Inc. shares are higher as CFO Mark Livingston prepares to present at the Wells Fargo Healthcare Conference on September 8, 2026.

2 sept. 2026, 20:08 UTC

Progyny Inc shares are higher today, continuing gains since Tuesday's close. The stock peaked earlier in the session before settling back.

1 sept. 2026, 23:41 UTC

Progyny Inc shares are higher in after-market hours, though no specific news was identified. The stock remains near its one-month range's lower end.

31 août 2026, 20:07 UTC

Progyny Inc. shares are lower as market sentiment shifts amid expectations of further interest rate hikes following the Jackson Hole Economic Symposium.

26 août 2026, 20:08 UTC

Progyny Inc shares are higher during Wednesday's session, continuing a notable gain since Tuesday. The stock remains below its 20-day moving average.

25 août 2026, 19:36 UTC

News

Progyny Inc. shares are advancing after reporting Q2 revenue growth of 5.3% and projecting full-year revenue between $1.36 billion and $1.385 billion.

24 août 2026, 19:36 UTC

Progyny Inc shares are lower today, reversing from earlier gains amid market volatility linked to geopolitical tensions and US sanctions against Iran.

20 août 2026, 19:31 UTC

News

Wells Fargo initiated coverage on Progyny Inc with an Overweight rating and a $37.00 price target, contributing to the stock's rise during Thursday's session.

18 août 2026, 20:06 UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

17 août 2026, 20:01 UTC

News

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

14 août 2026, 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13 août 2026, 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12 août 2026, 20:01 UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11 août 2026, 20:02 UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7 août 2026, 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 août 2026, 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 juil. 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 juil. 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 juil. 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 juil. 2026, 17:41 UTC

News
Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 juil. 2026, 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 juil. 2026, 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 juil. 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Comparaison

Variation de prix

Progyny Inc prévision

Objectif de Prix

By TipRanks

24.98% hausse

Prévisions sur 12 Mois

Moyen 34.182 USD  24.98%

Haut 40 USD

Bas 30 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

11 ratings

9

Achat

2

Maintien

0

Vente

Sentiment

By Acuity

9 / 339Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat